Combined, these results demonstrate that RGD4C-AAVP-TNF treatment of orthotopic glioma-bearing mice markedly suppressed tumor growth in a dose-dependent manner after sufficient TNF production to disrupt the tumor vasculature and to induce apoptosis in tumor cells. This evidence concerns the gene TNF and central nervous system cancer.